NEW YORK (GenomeWeb News) – Caliper Life Sciences said today that it has licensed its microfluidics patent portfolio to Becton Dickinson, effectively ending a prior legal dispute between Caliper and BD subsidiary HandyLab.

Last July, then-independent molecular diagnostics firm HandyLab sued Caliper seeking a declaration that it was not infringing Caliper's microfluidics patents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.